Versant Venture Management

Versant Venture Management as of Dec. 31, 2015

Portfolio Holdings for Versant Venture Management

Versant Venture Management holds 7 positions in its portfolio as reported in the December 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Glaukos (GKOS) 45.4 $78M 32M 2.42
Five Prime Therapeutics 26.5 $45M 1.1M 41.50
Ocular Therapeutix (OCUL) 12.2 $21M 2.2M 9.37
Clovis Oncology 8.3 $14M 407k 35.00
Achaogen 4.3 $7.4M 1.3M 5.74
Biotie Therapies Corp. ads 2.3 $3.9M 269k 14.35
Cymabay Therapeutics (CBAY) 1.0 $1.8M 1.0M 1.69